Pharmaceuticals · Pharmaceuticals: Major · NSE: INFINIUM · data 2026-10-30

Infinium Pharmachem Ltd.

₹281+1.08% on 30 OctHealth: Strong 6.9/10

Jan 2026Low ₹191.05 · High ₹314.25+29.9%

In plain words

Price: 13.4% below its 52-week high of ₹324.5.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹281

Market cap

₹433 cr

P/E

P/B

3.6

ROE

10.5%

ROCE

13.5%

Debt / equity

0.19

Dividend yield

0.00%

1-year return

8.0%

52-week high

₹324.5

52-week low

₹189.4

Operating margin

9.8%

Growth

Revenue (last 12 months)	₹190 cr
Net profit (last 12 months)	₹12 cr
Sales growth, 3 years (yearly)	18.4%
Profit growth, 3 years (yearly)	8.6%

Smart-money activity

5/100 · Weak over the last ~60 sessions

Delivery vs usual 0/30: No stored daily delivery history for this stock (0 points).
Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Common questions

Is Infinium Pharmachem Ltd. debt-free?

Its latest reported debt-to-equity ratio is 0.19.

What is Infinium Pharmachem Ltd.'s P/E ratio?

About 36, based on the last 12 months' earnings and a price of ₹281 (data 2026-10-30).

What is the 52-week high and low of Infinium Pharmachem Ltd.?

The 52-week high is ₹324.5 and the 52-week low is ₹189.4.

Similar companies

Praveg Limited (PRAVEG) · Albert David Ltd (ALBERTDAVD) · Jenburkt Pharmaceuticals Ltd (JENBURPH) · Medicamen Biotech Limited (MEDICAMEQ) · Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open INFINIUM in NSE Scanner →